Материалов:
1 005 012

Репозиториев:
30

Авторов:
761 409

По вашему запросу найдено документов: 165116

Страница 5 из 16512

Interleukin-1 Blockade with RPH-104 (Goflikicept) in Patients with ST-Segment Elevation Myocardial Infarction: Secondary End Points from an International, Double-Blind, Randomized, Placebo-Controlled, Phase 2a Study
Abbate A., Van Tassell B., Bogin V., Markley R., Pevzner D.V., Cremer P.C., Meray I.A., Privalov D.V., Taylor A., Grishin S.A., Egorova A.N., Ponomar E.G., Lavrovsky Y., Samsonov M.Y.
infarction (STEMI), goflikicept, an interleukin-1 blocker, significantly reduced systemic inflammation
Molecular mechanisms of splenectomy-induced hepatocyte proliferation
Elchaninov A.V., Fatkhudinov T.K., Vishnyakova P.A., Nikitina M.P., Lokhonina A.V., Makarov A.V., Arutyunyan I.V., Kananykhina E.Y., Poltavets A.S., Butov K.R., Baranov I.I., Goldshtein D.V., Bolshakova G.B., Glinkina V.V., Sukhikh G.T.
, including Ccne1, Egf, Tnfa, Il6, Hgf, Met, Tgfb1r2 and Nos2. The expression of Ccnd1, Tgfb1, Tgfb1r1 and Il
Irg1 expression in myeloid cells prevents immunopathology during M. tuberculosis infection
Nair S.
interleukin 6
Modulation of immunogenicity and conformation of HA1 subunit of influenza a virus H1/N1 hemagglutinin in tubular immunostimulating complexes
Sanina N.
interleukin 6
High glucose shifts the oxylipin profiles in the astrocytes towards pro-inflammatory states
Chistyakov D.V., Goriainov S.V., Astakhova A.A., Sergeeva M.G.
, and an imbalance between inflammatory cytokine (IL-6) and oxylipins release. These results suggest a regulation
Experience with the use of recombinant humanized monoclonal antibodies to the human receptor for interleukin-6 in patients with CoVID-19 [оПыт ПримеНеНия рекомбиНаНтНоГо ГумаНизироваННоГо моНоклоНальНоГо аНтитела к человечеСкому рецеПтору иНтерлейкиНа-6 у ПациеНтов С COVID-19]
Gusev D.А.
, D-dimer, interleukin-6, depending on the severity of the disease. The criteria for the appointment
The effect of Vitamin D therapy on inflammatory markers in patients with type 2 diabetes mellitus and diabetic peripheral polyneuropathy
Stepanova A.P.
(HbA1c), 25-hydroxyVitamin D (25(OH)D), PTH, interleukin-1β, -6, -10 (IL), C-reactive protein (CRP
Интерлейкиновый профиль у детей с острым бронхиолитом (предварительные данные)
Малахов А.Б., Анджель А.Е., Бережанский П.В., Елагина В.И., Горев В.В., Горбунов А.В., Седова А.Ю.
of various severity. All children had interleukins (IL) 4, 6, and 18 in their blood measured. Study Results
Interleukin-6 is a potential target for a correction of endothelial dysfunction associated with low-grade systemic inflammation
Kostina, D. A., Pokrovskaya, T. G., Beskhmelnitsyna, E. A.
diseases. To study the endothelium protective effects of anti-IL-6 receptor monoclonal antibodies
Effect of carvedilol and metoprolol CR administered with or without atorvastatin on elastic properties of vascular wall and parameters of inflammation in patients with chronic heart failure of ischemic origin
Ozova E.M., Kiyakbaev G.K., Kobalava Zh.D., Moiseev V.S.
interleukin 6

Страница 5 из 16512

Фасеты

Новости проекта

Новости

Партнеры

КФУ
ТГУ
Elpub
СФУ
Webpublishers

Индексация

BASE
WorldCat
OpenAIRE
EDS
core